Medicinefrom24/7 Wall St.1 day agoThese 5 Biotechs Could Be the Next Big GLP-1 Acquisition TargetThe GLP-1 revolution is driving biopharma M&A strategies, with companies like Viking Therapeutics and Structure Therapeutics as prime acquisition targets.
BostonfromBoston.com3 days agoMajor pharmaceutical company to cut nearly 250 Massachusetts jobsTakeda is laying off nearly 250 employees in Cambridge as part of a restructuring plan to save $1.25 billion annually by 2028.
LawfromThe Verge8 months agoErrors found in US judge's withdrawn decision stink of AIA U.S. district court judge withdrew his decision due to errors including fake quotes and incorrect case information.